Nature, Vol.588, No.7838, 398-399, 2020
Engineered antibodies to combat viral threats
As the COVID-19 pandemic rages globally, interest in antiviral treatments has never been higher. Antibodies are key defence components, and engineering them to better exploit their natural functions might boost therapeutic options.